What happened
SK biopharmaceuticals disclosed a supply contract with SK Life Science,Inc., worth US$29.5M, about 8.1% of its recent annual revenue, running through Mar 2026.
For context, this single contract equals about 8.1% of the company's most recent annual revenue.
| Counterparty | SK Life Science,Inc. |
|---|---|
| Contract value | US$29.5M |
| vs. recent revenue | 8.1% |
| Through | Mar 2026 (from Mar 2026) |
| Filed | 2026-03-26, Supply contract signed |
| Source | DART rcept 20260326800819 → open original filing |
Source: DART. Information only, not investment advice.